Centre maps 19 states with Remdesivir manufacturers for smooth supply

"This allocation pertains to 14 states to which medical oxygen is allocated and five other states where the high volume of supplies are being observed," the centre said.

Under this allocation, the UT of Delhi will be getting 61,900 vile of Remdesivir, Chhattisgarh- 48,250, Gujarat- 163,500, Haryana- 29500, Andhra Pradesh-59,000, Madhya Pradesh-92,000, Maharashtra-269,200,Punjab- 13,400,Rajasthan- 26.500,Tamilnadu- 58,900,Uttar Pradesh- 122,800 Uttarakhand-13,500, Karnataka-25,400 and Kerala-16,100.

The Centre has also cautioned the States that Remdesivir being an investigational therapy drug given in acute and severe versions of COVID-19 where oxygen support is a must, this allocation pertains to 14 States to which medical oxygen is allocated and five other states where the high volume of supplies are being observed and also asked states to take action against possible hoarding and black marketing of the drug.

The Government has  directed the pharma companies to augment the production of this medicine's  manufacturers has been ramped up and all support have been extended to manufacturers by the government in this endeavour. 

The production capacity is being ramped up from a current level of 38 lakh vials per month to 74 lakh vials per month, and 20 additional manufacturing sites have been approved. 

Export of Remdesivir has also been prohibited in order to shore up domestic supplies.

The manufacturers have been advised to consider supply orders already made to them, geographical proximity with a State and terms of supply and give inputs for mapping of manufacturers to states for the allocated volumes.

Manufacturers have been directed to manufacture and dispatch the supplies as per the agreed State allocation and mapping. They may be asked to balance supplies to the Government and distribution channel.

"All States may place their supply orders to manufacturers, if not already done, either by Government purchase or distribution channel, within the above-mentioned State-wise allocation and manufacturer-wise mapping," the Centre said .

In case any State does not require or is unable to fully utilize its allocation before April 30, that would be available for reallocation to other States as per their requirement.

"The States may immediately appoint State Nodal officers for Remdesivir who will be responsible for unrestricted and timely movement of Remdesivir within their States as per the above-mentioned allocation and mapping," the Central government stated.

Control Room set up by National Pharmaceutical Pricing Authority (NPPA) shall be responsible for monitoring the operations as per the allocations. 
A Whatsapp group comprising Nodal officers of States to coordinate unhindered movement of Remdesivir within the country is being created. 

Liaison Officers of the Remdesivir manufacturers and officials of Ministry of Home Affairs, Dept of Pharmaceuticals, National Pharmaceutical Pricing Authority (NPPA) and Central Drugs Standard Control Organisation (CDSCO) would be part of this Group for day to day monitoring and coordination.